Xenon Pharmaceuticals announced the appointment of Andrea DiFabio as Chief Legal Officer, CLO, and Corporate Secretary, effective immediately. DiFabio will provide strategic leadership and oversight of the planning and execution for Xenon’s legal function on a global basis. Prior to joining Xenon, DiFabio was the Chief Legal & Administrative Officer and Corporate Secretary at Repertoire Immune Medicines from March 2020 to October 2022.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on XENE:
- Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
- Raymond James starts ‘rare opportunity’ Xenon with Outperform
- Xenon Pharmaceuticals initiated with an Outperform at Raymond James
- Xenon Pharmaceuticals price target raised to $49 from $46 at RBC Capital